John E. Imhoff - 06 Mar 2025 Form 4/A - Amendment Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director, 10%+ Owner
Signature: /s/ John E. Imhoff
Issuer symbol: GTHP
Transactions as of: 06 Mar 2025
Net transactions value: +$2,813,007
Form type: 4/A - Amendment
Filing time: 23 May 2025, 14:16:41 UTC
Date Of Original Report: 17 Apr 2025
Previous filing: 18 Feb 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Imhoff John E	Director, 10%+ Owner	5853 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS	/s/ John E. Imhoff	23 May 2025	0001348439

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Preferred Series D Stock	Other		-300	-100%		0	06 Mar 2025	Direct	F1
transaction	GTHP	Common Stock	Other		+900,000	+10%		9,662,756	06 Mar 2025	Direct	F1
transaction	GTHP	Preferred Series C2 Stock	Other		-2,401	-100%		0	06 Mar 2025	Direct	F2
transaction	GTHP	Common Stock	Other	$2,400,750	+4,801,500	+50%	$0.5000	14,464,256	06 Mar 2025	Direct
transaction	GTHP	Preferred Series C Stock	Purchase		+286			286	07 Mar 2025	Direct	F3
transaction	GTHP	Preferred Series C Stock	Other		-286	-100%		0	11 Mar 2025	Direct	F3
transaction	GTHP	Common Stock	Other	$285,950	+2,258,690	+16%	$0.1266	16,722,946	11 Mar 2025	Direct
transaction	GTHP	Preferred Series E Stock	Purchase		+150	+60%		400	13 Mar 2025	Direct	F4
transaction	GTHP	Common Stock	Purchase	$100,000	+1,000,000	+6%	$0.1000	17,722,946	18 Mar 2025	Direct	F5
transaction	GTHP	Common Stock	Purchase	$26,307	+263,069	+1.5%	$0.1000	17,986,015	18 Mar 2025	Direct	F6
transaction	GTHP	Common Stock	Other		+6,365	+0.04%		17,992,380	10 Apr 2025	Direct	F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Warrants	Purchase		+1,000,000			1,000,000	18 Mar 2025	Common Stock	1,000,000	$0.1300	Direct	F5
transaction	GTHP	Warrants	Purchase		+263,069	+26%		1,263,069	18 Mar 2025	Common Stock	263,069	$0.1300	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.
F2	On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.
F3	On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.
F4	On March 13, 2025, for a purchase price of $30,000, Mr. Imhoff purchased 150 shares of Series E preferred stock from a third party. The shares have a conversion price of $0.25 and a stated value of $1,000.
F5	In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.
F6	These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.
F7	These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.